Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Mei, Mei ^a   Zhao, Lei ^a   Li, Qing ^a   Chen, Yaxi ^a   Huang, Ailong ^a   Varghese, Zac ^b   Moorhead, John F ^b   Zhang, Suhua ^a   Powis, Stephen H ^b   Li, Qifu ^a   Ruan, Xiong Z ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

acetyl CoA carboxylase; adipose triglyceride lipase; fatty acid synthase; sterol regulatory element binding protein1

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACETYL COENZYME A CARBOXYLASE ALPHA; ADIPOSE TRIGLYCERIDE LIPASE; CASEIN; CYTOKINE; FATTY ACID; FATTY ACID SYNTHASE; HORMONE SENSITIVE LIPASE; INTERLEUKIN 6; MESSENGER RNA; SERUM AMYLOID A; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; FASN PROTEIN, HUMAN; INSULIN; SREBF1 PROTEIN, HUMAN;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DISEASE; CHRONIC SYSTEMIC INFLAMMATORY STRESS; CONTROLLED STUDY; DISEASE EXACERBATION; DYSLIPIDEMIA; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; IN VIVO STUDY; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID ANALYSIS; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; LIVER; MOUSE; MUSCLE TISSUE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; GENETICS; GLUCOSE BLOOD LEVEL; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM; PATHOLOGY; PHYSIOLOGICAL STRESS; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

MUS;

ACETYL-COA CARBOXYLASE; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; CASEINS; FATTY ACID SYNTHETASE COMPLEX, TYPE I; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LIPID METABOLISM; LIVER; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; SERUM AMYLOID A PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STRESS, PHYSIOLOGICAL;

EID: 79959679615     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-110     Document Type: Article

References (27)

1. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. GF Lewis A Carpentier K Adeli A Giacca, Endocr Rev 2002 23 201 29 10.1210/er.23.2.201 11943743 (Pubitemid 34299024)
2. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. M Bajaj S Suraamornkul P Piper LJ Hardies L Glass E Cersosimo T Pratipanawatr Y Miyazaki RA DeFronzo, J Clin Endocrinol Metab 2004 89 200 6 10.1210/jc.2003-031315 14715850 (Pubitemid 38183882)
3. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. A Seppala-Lindroos S Vehkavaara AM Hakkinen T Goto J Westerbacka A Sovijärvi J Halavaara H Yki-Järvinen, J Clin Endocrinol Metab 2002 87 3023 8 10.1210/jc.87.7.3023 12107194 (Pubitemid 34816338)
4. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. L Ryysy AM Hakkinen T Goto S Vehkavaara J Westerbacka J Halavaara H Yki-Järvinen, Diabetes 2000 49 749 58 10.2337/diabetes.49.5.749 10905483 (Pubitemid 30339990)
5. Skeletal muscle triglyceride levels are inversely related to insulin action. DA Pan S Lillioja AD Kriketos MR Milner LA Baur C Bogardus AB Jenkins LH Storlien, Diabetes 1997 46 983 8 10.2337/diabetes.46.6.983 9166669 (Pubitemid 27220998)
6. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. BH Goodpaster DE Kelley RR Wing A Meier FL Thaete, Diabetes 1999 48 839 47 10.2337/diabetes.48.4.839 10102702 (Pubitemid 29153085)
7. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. BH Goodpaster FL Thaete JA Simoneau DE Kelley, Diabetes 1997 46 1579 85 10.2337/diabetes.46.10.1579 9313753 (Pubitemid 27411233)
8. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? JR Greenfield LV Campbell, Curr Diabetes Rev 2006 2 195 211 10.2174/157339906776818532 18220627 (Pubitemid 44082940)
9. Adipokines in liver diseases. F Marra C Bertolani, Hepatology 2009 50 957 69 10.1002/hep.23046 19585655
10. The metabolic effects of tumor necrosis factor and other cytokines. C Grunfeld KR Feingold, Biotherapy 1991 3 143 58 10.1007/BF02172087 2054255
11. Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). G Medina-Gomez S Gray A Vidal-Puig, Public Health Nutr 2007 10 1132 7 17903321 (Pubitemid 350085201)
12. SREBP transcription factors: master regulators of lipid homeostasis. D Eberle B Hegarty P Bossard P Ferre F Foufelle, Biochimie 2004 86 839 48 10.1016/j.biochi.2004.09.018 15589694 (Pubitemid 39602764)
13. sterol-regulated transcription factors. PJ Espenshade SREBPs, J Cell Sci 2006 119 973 6 10.1242/jcs02866 16525117
14. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. KL Ma XZ Ruan SH Powis Y Chen JF Moorhead Z Varghese, Hepatology 2008 48 770 81 10.1002/hep.22423 18752326
15. Visceral fat obesity: anthropological and pathophysiological aspects. S Tarui K Tokunaga S Fujioka Y Matsuzawa, Int J Obes 1991 15 Suppl 2 1 8 1917279
16. Inflammation, stress, and diabetes. KE Wellen GS Hotamisligil, J Clin Invest 2005 115 1111 9 15864338 (Pubitemid 40629025)
17. Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection. K Miura Y Takahashi H Shirasawa, Lab Invest 1985 53 453 63 3900582 (Pubitemid 16243362)
18. Localized inflammation in peripheral tissue signals the CNS for sickness response in the absence of interleukin-1 and cyclooxygenase-2 in the blood and brain. H Zhang S Ching Q Chen Q Li Y An N Quan, Neuroscience 2008 157 895 907 10.1016/j.neuroscience.2008.09.038 18950689
19. Effects of dietary fatty acids on insulin sensitivity and secretion. M Manco M Calvani G Mingrone, Diabetes Obes Metab 2004 6 402 13 10.1111/j.1462-8902.2004.00356.x 15479216 (Pubitemid 39409791)
20. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. YH Yu HN Ginsberg, Circ Res 2005 96 1042 52 10.1161/01.RES. 0000165803.47776.38 15920027 (Pubitemid 40791376)
21. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. KM Korenblat E Fabbrini BS Mohammed S Klein, Gastroenterology 2008 134 1369 75 10.1053/j.gastro.2008.01.075 18355813 (Pubitemid 351615354)
22. Signaling pathways in insulin action: molecular targets of insulin resistance. JE Pessin AR Saltiel, J Clin Invest 2000 106 165 9 10.1172/JCI10582 10903329 (Pubitemid 30483117)
23. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. AJ Sanyal C Campbell-Sargent F Mirshahi WB Rizzo MJ Contos RK Sterling VA Luketic ML Shiffman JN Clore, Gastroenterology 2001 120 1183 92 10.1053/gast.2001.23256 11266382 (Pubitemid 32246672)
24. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. A Wieckowska BG Papouchado Z Li R Lopez NN Zein AE Feldstein, Am J Gastroenterol 2008 103 1372 9 10.1111/j.1572-0241.2007.01774.x 18510618 (Pubitemid 351813900)
25. Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure. A Canbay LP Bechmann J Best C Jochum U Treichel G Gerken, Z Gastroenterol 2006 44 245 8 10.1055/s-2006-926502 16514570
26. Non-alcoholic fatty liver disease in HIV-positive patients predisposes for acute-on-chronic liver failure: two cases. A Kahraman M Miller RK Gieseler G Gerken MJ Scolaro A Canbay, Eur J Gastroenterol Hepatol 2006 18 101 5 10.1097/00042737-200601000-00018 16357628 (Pubitemid 43004890)
27. Hepatic steatosis and type 2 diabetes mellitus. JM Clark AM Diehl, Curr Diab Rep 2002 2 210 5 10.1007/s11892-002-0085-3 12643175